Free Trial

MiNK Therapeutics (INKT) SEC Filings & 10K Form

MiNK Therapeutics logo
$15.09 -0.26 (-1.69%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$15.15 +0.06 (+0.40%)
As of 09/19/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MiNK Therapeutics SEC Filings

DateFilerForm TypeView
09/11/2025
3:46 PM
Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
3:05 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
3:05 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
3:05 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
3:05 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
3:05 PM
Kadlec Robert Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
4:26 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
4:28 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
4:29 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
4:30 PM
Kadlec Robert Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
4:33 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025
4:02 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2025
3:05 PM
MiNK Therapeutics (Filer)
Form 424B5
08/14/2025
6:35 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
6:00 AM
MiNK Therapeutics (Filer)
Form 424B5
07/15/2025
6:05 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
6:45 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:05 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Kadlec Robert Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
4:03 PM
MiNK Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:52 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:17 PM
MiNK Therapeutics (Filer)
Form DEF 14A
12/06/2024
4:09 PM
MiNK Therapeutics (Filer)
Form PRE 14A
12/03/2024
9:35 AM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:38 AM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:44 AM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:44 AM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:15 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INKT) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners